The largest database of trusted experimental protocols

Apotox glo assay

Manufactured by Promega
Sourced in United States

The ApoTox-Glo assay is a multiplex kit that enables the simultaneous measurement of viability, cytotoxicity, and apoptosis within the same cell population. The assay utilizes fluorogenic peptide substrates to detect distinct protease activities associated with live and dead cells, as well as an apoptosis-associated caspase activity.

Automatically generated - may contain errors

12 protocols using apotox glo assay

1

Cytotoxic Effects of Piptoporus betulinus and Betulin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of Piptoporus betulinus extract and the saturated ethanolic solution of betulin on Hs27, WM115, and A375 cells was tested by cell viability assays: colorimetric CellTiter (G4000, Promega, Madison, WI, USA) and fluorometric alamarBlue (DAL1025, Thermo Fisher, Waltham, MA, USA), cytotoxic lactate dehydrogenase (LDH) activity test (MAK066, Sigma-Aldrich, St. Louis, MO, USA), as well as ApoTox-Glo assay (G6320, Promega, Madison, WI, USA) were used to analyze both cell viability and apoptosis.
Cells, detached by trypsinization and counted after trypan blue staining (Bio-Rad, TC-10, Hercules, CA, USA), were seeded in 96-well flat-bottomed plates (1–2 × 104 cells per well), either transparent (TPP) or black (Invitrogen, Paisley, UK), and incubated overnight. Cells in each plate were treated for 24 h with different concentrations of Piptoporus betulinus ethanolic extract (1, 2.5, 5, and 10 μL mL−1), the saturated ethanolic betulin solution (0.01, 0.05, 0.25, 1, 5, 7.5, and 10 μL mL−1), or the highest concentration (10 μL mL−1) of ethanol (EtOH) (Figure 7).
+ Open protocol
+ Expand
2

Evaluating Targeted Knockdown Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial pLKO shRNA clones (4-10 per gene) were obtained from the Molecular Phenotyping Laboratory at MGH. Lentiviral stocks were produced according to the RNAi Consortium protocol from the Broad Institute. Protein knockdown efficiency was determined by western blotting using A549 cells, and hairpins with the best knockdown were selected for use (Table S2). Cell lines were infected with lentivirus in an arrayed 96-well format at viral concentrations 2-3x MOI. After 24 hours, the virus was removed and cells were cultured for 48 hours in normal media. Cells were then treated with 1 μM AZD6244/GDC-0941 for 48 hours and cell viability and caspase 3/7 activity were determined ApoTox-Glo assay (Promega).
+ Open protocol
+ Expand
3

Quantifying Caspase Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The kit used was the ApoTox-Glo Assay from Promega Corporation (Fitchburg, WI, USA). This assay measures caspase activation 3/7 within a single assay well using the Caspase-Glo Assay Technology. The luminogenic caspase 3/7 substrate is added (100 μL) and plates are incubated at room temperature for 30–60 minutes. The caspase cleavage of the substrate generates a “glow-type” luminescent signal produced by luciferase. The same principle and protocol apply to the kits Caspase-Glo 8 and 9 (Promega Corporation) used to determine caspase 8 and 9 activities. Luminescence (RLU) reading is proportional to the amount of caspases 3/7, 8 and 9 activity present in each well.
+ Open protocol
+ Expand
4

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
2500–10,000 cells were plated in DMEM medium in transparent flat-bottomed 384- or 96-well plates. Twenty-four hours later, the drugs were added at different concentrations and left for the indicated time. 48h viability of the cells in response to the compounds was assessed using ApoToxGlo Assay (Promega Biotech AB, Sweden) or CellTiterGlo (Promega Biotech AB, Sweden) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
5

Temporal Analysis of miR-124 Depletion

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT and ΔmiR-124 were seeded and differentiated consecutively according to the time frame from 0 to 14 dpi and all samples were measured with a SynergyNeo2 plate reader (BioTek) on the same day. The ApoToxGlo assay (G6320, Promega) was conducted according to the manufacturer’s protocol. Statistical comparison was performed using unpaired Student’s t-tests and Holm-Sidak correction for multiple comparisons. Data are presented as mean ± SEM.
+ Open protocol
+ Expand
6

Multiplex Detection of Cell Viability, Necrosis, and Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ApoTox‐Glo® assay (Promega) is a multiplex method that simultaneously detects three different protease activities as markers for viable, necrotic, and apoptotic cells in a single sample and was used following the manufacturer’s protocol. A673 EwS cells were treated with Y15 (10 µm) or volume‐adapted concentrations of DMSO for 24 h. Free AFC as a marker of viable cells was determined by the measurement of fluorescence at 400 nm excitation/505 nm emission wavelengths; free R110 as a marker of necrotic cells was measured at 485 nm excitation/520 nm emission. Thirty minutes after adding Caspase‐Glo® 3/7 reagent, the release of aminoluciferin was measured using a luminometer. All tests were performed in triplicate and normalized to control (background), vehicle (DMSO), and Y15 compound controls.
+ Open protocol
+ Expand
7

Quantifying Cell Death and Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell death and cytotoxicity were measured using the CytoTox96 Non-Radioactive Cytotoxicity Assay according to manufacturer’s protocols (Promega, Madison, WI). Cell viability, cytotoxicity, and apoptosis were also measured using the ApoTox-Glo assay according to manufacturer’s protocols (Promega). Briefly, J774 cells were plated at 2×104 cells/well in 100μl of media in a clear bottomed, opaque walled 96-well plate overnight in phenol red and serum free media. The next day, the cells were treated as indicated, mixed with Viability/Cytotoxicity Reagent and incubated for 30 minutes before reading on a Synergy HTX Multi-Mode plate reader (BioTek, Winooski, VT) using the program Gen5 1.1 at 400Ex/505Em (viability) and 485Ex/520Em (cytotoxicity). Immediately following, cells were mixed with Caspase-Glo 3/7 Reagent, mixed, incubated for 2 hours, and apoptosis was measured by luminescence.
+ Open protocol
+ Expand
8

Apoptosis Induction by Rubiq and Rubpy

Check if the same lab product or an alternative is used in the 5 most similar protocols
hS5 and 10T1/2 cells were plated at 1500 cells per well in a white-walled 96-well plate. 24 h after plating, cells were exposed to Rubiq, Rubpy, or Rubiq/Rubpy prereacted with mono-PEG-BCN at a final concentration of 1 mM in the appropriate growth media for 3 h. 24 h after exposure, caspase 3 levels were determined via the ApoTox Glo assay, where an increase in luminescence indicates increased levels of caspase 3 and the presence of apoptotic cells (Promega).
+ Open protocol
+ Expand
9

Validating Kinase Targets in HNSCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten kinase targets were further validated in a 96 well format in five additional HNSCC cell lines (UM-SCC22A, UM-SCC22B, UM-SCC38, UM-SCC47A, JHU-019). In addition, the ten HFF exclusion kinase targets were included in the low-throughput assay (i.e., 20 kinase targets). This assay consisted of three independent siRNAs per well (pooled siRNAs) assayed in triplicate (Qiagen, Table S7) for cell viability and apoptosis measured at 1.5, 3, and 4.5 days post-transfection utilizing the Apotox-Glo assay (Promega, Madison, WI) as per manufacturers specifications utilizing a Synergy H4 Hybrid Multi-Mode microplate reader (Biotek). Statistical significance of RNA interference mediated knockdown of the 20 kinases was assessed via ANOVA with Dunnetts post-test for multiple comparisons on absolute viability (day 4.5), differential viability (day 4.5 - day 1.5), and area under the curve (AUC) analysis of caspase-dependent apoptosis versus the negative siRNA control (SINC) (Tables S18–S20).
+ Open protocol
+ Expand
10

Caspase-3/7 Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Apoptosis was measured by caspase-3/7 activation with the ApoTox-Glo assay (Promega) as per the manufacturer’s instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!